<DOC>
	<DOC>NCT01050595</DOC>
	<brief_summary>The purpose of this study is to determine if there will be a significantly higher incidence of a bowel movement with methylnaltrexone vs. placebo within 4 hours +- 45 minutes with decreased need for rescue medications in the intensive care unit in patients with opioid-induced constipation. Patients will also be managed with an aggressive bowel management protocol.</brief_summary>
	<brief_title>Methylnaltrexone for Treatment of Opiate-Induced Constipation in the Intensive Care Unit</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>18 years of age or older in the ICU Opioids for analgesia for at least 24 hours. Opioidinduced constipation with no bowel movement within the last 72 hours. Women of childbearing potential had negative pregnancy tests. Contraindication to use of the GI tract Diarrhea on admission Bowel surgery within 8 weeks of admission Ileostomy or colostomy Not expected to live or stay more than 3 days in the intensive care unit Constipation that was not primarily caused by opioids (as determined by the investigator) No opioid use in the last 24 hours, Mechanical gastrointestinal obstruction An indwelling peritoneal catheter Clinically active diverticular disease Fecal impaction Acute surgical abdomen History of Crohn's disease or ulcerative colitis On Palliative care Less than 18 years old Bowel movement in last 72 hours.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Constipation</keyword>
	<keyword>Bowel Management</keyword>
</DOC>